Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/16 → 12/31/16 |
A Randomized, Multicenter, Open Label Study of MM-302 plus Trastuzumab vs. Chemotherapy of Physician’s Choice plus Trastuzumab in Anthracycline Naive Patients with Locally Advanced/Metastatic HER2-Positive Breast Cancer
- Mathew, Aju (PI)